ChemicalBook >> CAS DataBase List >>marinobufagenin
marinobufagenin
- CAS No.
- 470-42-8
- Chemical Name:
- marinobufagenin
- Synonyms
- Marinobufagin;Marinobufogenin;marinobufagenin;Marinobufagin（Marinobufagenin）;3β,5β-Dihydroxy-14β,15β-epoxybufa-20,22-dienolide;3β,5-Dihydroxy-14,15β-epoxy-5β-bufa-20,22-dienolide;14,15β-Epoxy-3β,5-dihydroxy-5β-bufa-20,22-dienolide;(3β,5β,15β)-3,5-Dihydroxy-14,15-epoxybufa-20,22-dienolide;Bufa-20,22-dienolide, 14,15-epoxy-3,5-dihydroxy-, (3β,5β,15β)-;5-((1R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethylhexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-1-yl)-2H-pyran-2-one
- CBNumber:
- CB61360037
- Molecular Formula:
- C24H32O5
- Molecular Weight:
- 400.52
- MDL Number:
- MFCD32661898
- MOL File:
- 470-42-8.mol
- MSDS File:
- SDS
Last updated:2023-05-21 10:59:17
| Melting point | 224-225 °C |
|---|---|
| Boiling point | 589.0±50.0 °C(Predicted) |
| Density | 1.31±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMF: 3 mg/ml; DMF:PBS (pH 7.2) (1:8): 0.1 mg/ml; Ethanol: 1 mg/ml |
| form | A crystalline solid |
| pka | 14.77±0.70(Predicted) |
| FDA UNII | 3KBT25GV2B |
marinobufagenin price More Price(11)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 20798 | Marinobufagenin ≥98% | 470-42-8 | 500μg | $57 | 2024-03-01 | Buy |
| Cayman Chemical | 20798 | Marinobufagenin ≥98% | 470-42-8 | 1mg | $107 | 2024-03-01 | Buy |
| Cayman Chemical | 20798 | Marinobufagenin ≥98% | 470-42-8 | 5mg | $467 | 2024-03-01 | Buy |
| Biosynth Carbosynth | FM167440 | Marinobufagenin | 470-42-8 | 5mg | $550 | 2021-12-16 | Buy |
| Medical Isotopes, Inc. | 73875 | Marinobufagin 98% | 470-42-8 | 5mg | $590 | 2021-12-16 | Buy |
marinobufagenin Chemical Properties,Uses,Production
Uses
Marinobufagin is a bufadienolide with anti-gastric cancer effect. A bioactive steroid that also functions as an endogenous Na/K-ATPase bufadienolide inhibitor that plays a major role in human cardiovascular diseases.
Definition
ChEBI: Marinobufagenin is a cardiotonic steroid secreted by the toad Bufo rubescens and other related species such as Bufo marinus. An endogenous Na/K-ATPase inhibitor, it is a vasoconstrictor with effects similar to digitalis. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor and an epitope. It is a steroid hormone and an epoxy steroid. It is functionally related to a (5beta)-bufadienolide.
marinobufagenin Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 45)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3620 | 58 |
| Chengdu GLP biotechnology Co Ltd | 028-87075086 13350802083 | scglp@glp-china.com | CHINA | 1824 | 58 |
| Chengdu Biopurify Phytochemicals Ltd. | +8618080483897 | sales@biopurify.com | China | 3424 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| TopScience Biochemical | 00852-68527855 | info@itopbiochem.com | China Hong Kong | 902 | 58 |
| LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24738 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33350 | 58 |
| Nanjing Chemlin Chemical Co., Ltd | 025-83697070 | info@chemlin.com.cn | China | 18089 | 64 |
| Nanjing Endesa Bio-tech Co., Ltd. | 025-58862853 18915922038 | sales@endesachem.com | China | 592 | 58 |
470-42-8(marinobufagenin)Related Search:
marinobufagenin
14,15β-Epoxy-3β,5-dihydroxy-5β-bufa-20,22-dienolide
3β,5-Dihydroxy-14,15β-epoxy-5β-bufa-20,22-dienolide
3β,5β-Dihydroxy-14β,15β-epoxybufa-20,22-dienolide
Marinobufagin
Marinobufogenin
(3β,5β,15β)-3,5-Dihydroxy-14,15-epoxybufa-20,22-dienolide
Bufa-20,22-dienolide, 14,15-epoxy-3,5-dihydroxy-, (3β,5β,15β)-
Marinobufagin（Marinobufagenin）
5-((1R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethylhexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-1-yl)-2H-pyran-2-one
470-42-8
Vasoconstrictor Agents
Enzyme Inhibitors